Korean red ginseng saponins (ginsenosides) have been reported as having various biological properties, but the antifungal effects and the mode of action of ginsenosides remain mostly unknown. In this study, saponins were isolated from Korean red ginseng, and the antifungal effects of ginsenosides were investigated. Ginsenosides showed fungicidal effects toward pathogenic fungi tested. To elucidate the antifungal mode of action of ginsenosides, flow cytometry analysis and the change in membrane dynamics using 1,6-diphenyl-1,3,5-hexatriene (DPH), as a plasma membrane probe, were performed with Candida albicans. The results suggest that ginsenosides may exert antifungal activity by disrupting the structure of cell membrane. The present study indicates that ginsenosides have considerable antifungal activity, deserving further investigation for clinical applications.
The risk of opportunistic infections is greatly increasing in patients who are immunocompromised due to cancer chemotherapy, organ or bone marrow transplantation, or human immunodeficiency virus infection. 1) Candida albicans is the organism most often associated with both mucosal and hematogenously disseminated infections. 2, 3) Both drug resistance and toxicity are associated with existing antifungal drugs to more efficiently manage systemic fungal infections. Several potential new antifungal targets are being investigated in a search for novel drugs with reduced toxicity and less likelihood of resistance.
The use of natural products, with therapeutic properties, is as ancient as human civilization and, for a long time, minerals, plants and animal products were the main sources of drugs. 4) In particular, plants produce an enormous array of secondary metabolites, and it is commonly accepted that a significant part of this chemical diversity serves to protect plants against microbial pathogens.
5) Therefore, in recent years, there has been growing interest in alternative therapies and in the therapeutic use of natural products, especially those derived from plants. 6) Ginseng has been used for thousands of years in Asian countries, particularly in China, Korea and Japan, due to its wide spectrum of medicinal effects, such as tonic, immunomodulatory and anti-aging activity. 7) Many of its medicinal effects can be attributed to triterpene glycosides known as ginsenosides. Ginsenosides have been reported as having a variety of anticancer effects. Several studies have demonstrated that ginsenosides possess chemopreventive properties. For example, the oral administration of ginsenosides in rats dosed with a carcinogen such as 7,12-dimethylbenz[a]anthracene [DMBA], urethane or aflatoxin B1, reduces the incidence and size of the tumors that developed. 8) Ginsenosides also have a radioprotective effect against radiation-induced double-strand breaks in DNA and immunomodulatory activity, as evidenced by its stimulation of natural killer cells. 9, 10) Although various biological activities of ginsenosides are known, the antifungal effects and the mode of action of ginsenosides remain mostly unknown.
In this report, we investigated antifungal activity and the mode of action of ginsenosides against pathogenic fungi tested.
MATERIALS AND METHODS

Chemicals
The following drugs were obtained from the indicated commercial sources: YPD broth (Difco, Detroit, MI, U.S.A.); bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC 4 (3) ], 1,6-diphenyl-1,3,5-hexatriene (DPH) (Molecular probes, Eugene, Oregon, U.S.A.); fetal bovine serum (FBS) (Cansera International Inc., Rexdale, ON, Canada); amphotericin B, dimethyl sulfoxide (DMSO), 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and other chemicals (Sigma Chemical Co., St. Louis, MO, U.S.A.). Stock solution of amphotericin B was prepared in DMSO and stored at Ϫ20°C. For all the experiments, final concentration of 2% DMSO was used as solvent carrier.
Preparation of Ginsenosides Korean red ginseng (KRG, the steamed root of Panax ginseng C. A. MEYER, family Araliaceae) was obtained from the Korea Ginseng and Tabacco Research Institute, Daejeon, Korea, and its voucher specimen has been deposited in the same institution. KRG saponins were extracted with 80% MeOH (1 ml) from freezedried ginseng hairy root tissue (1 g) and sonicated at 40°C for 1 h. The methanol extract was centrifuged at 1000 rpm for 10 min and evaporated. The dried pellet was re-extracted with water-saturated n-BuOH. After evaporating n-BuOH phase to dryness, pellet (54 mg) was dissolved in sterile distilled water (10 mg/ml as a final concentration). The isolated ginsenosides was analyzed by using HPLC system. Twenty microliter of ginsenosides solution was injected onto HPLC equipped with a UP-ODS C 18 column (4.6 mmϫ250 mm; Shimadzu, Kyoto, Japan) at room temperature. The mobile phase consisted of water (solvent A) and acetonitrile (solvent B) and the flow rate was 1.0 ml/min. Gradient elution started with 85% solvent A and 15% solvent B, changed to 20% B for 15 min, then was changed to 30% B for 25 min; changed to 40% B for 10 min; changed to 60% B for 20 min; changed to 80% B for 10 min; changed to 85% B for 3 min; changed to 15% B for 7 min and was held for 10 min. The detection wavelength was set to 202 nm. The HPLC instrumentation included an Shimadzu CBM-20A/20Alite system controller, a Shimadzu LC-20AD pump, a Shimadzu DGU-20A 3 degasser, a Shimadzu SPD-20A detector, an HPLC auto sampler 7125 (Rheodyne, U.S.A.), and an computer running Shimadzu software version LCsolution. Ginsenosides contained Rb 1 (25%), Rb 2 (11.9%), Rc (12.5%), Rd (6.1%), Re (13.4%), Rf (4.4%), Rg 1 (14.6%), Rg 2 (3.6%), Rg 3 (3.4%), Rh 2 (3.6%) and other minor ginsenosides.
Microorganisms and Culture Conditions Saccharomyces cerevisiae (KCTC 7296) and Trichosporon beigelii (KCTC 7707) were obtained from the Korean Collection for Type Cultures (KCTC) at the Korea Research Institute of Bioscience and Biotechnology (KRIBB, Daejeon, Korea). Candida albicans (TIMM 1768) was obtained from the Center for Academic Societies (Osaka, Japan). The fungal cells were cultured in a YPD broth containing yeast extract, peptone, dextrose (50 g/l) with aeration at 28°C.
Determination of Antifungal Susceptibility The fungal cells (2ϫ10 4 /ml) were inoculated into an YPD broth and dispensed at 0.1 ml/well in 96-well microtiter plates. MICs were determined by a serial two-fold dilution of test compounds, following the micro-dilution method 11) and MTT assay.
12)
After 48 h of incubation at 28°C, the minimal compound concentration that prevented the growth of a given test organism was determined and was defined as the MIC. Growth was assayed with a microtiter ELISA reader by monitoring absorption at 580 nm. MIC values were determined by three independent assays.
Kinetics of Fungal Killing
The kinetics of fungal killing of the ginsenosides were evaluated by using C. albicans cells. Log-phase fungal cells (2ϫ10 4 CFU/ml) were incubated with 100 mg/ml of ginsenosides or 2.5 mg/ml of amphotericin B. The culture were obtained and spread on an YPD agar plate, and then the colony forming units (CFUs) were counted after 24 h incubation at 28°C. 13) The results represent the average of triplicate measurements from three independent assays.
Effect of Ginsenosides on the Dimorphic Transition C. albicans cells were maintained by periodic subculturing in a liquid YPD medium. The cultures of yeast cells (blastoconidia) were maintained in a liquid YPD medium at 37°C. To induce mycelial formation, cultures were directly supplemented with a 20% FBS. The dimorphic transition in C. albicans was investigated from cultures containing 100 mg/ml of ginsenosides, incubated for 48 h at 37°C.
14) The dimorphic transition to mycelial forms was detected by phase contrast light microscopy (NIKON, ECLIPSETE300, Tokyo, Japan).
Flow Cytometric Analysis for the Plasma Membrane Potential Log-phased cells of C. albicans (2ϫ10 8 cells), cultured in an YPD medium, were harvested and resuspended with 1 ml of a fresh YPD medium containing 1 or 2 mg/ml of ginsenosides. After incubation for 3 h, the cells were washed with a PBS (35 mM phosphate buffer/150 mM NaCl, pH 7.4) three times. To detect of the depolarization of the cell membrane, 1 ml PBS containing 50 mg/ml of [DiBAC 4 (3)], was added and the samples were incubated in the dark at 4°C for 1 h. 15) A flow cytometric analysis was performed using a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA, U.S.A.).
Measurement of Plasma Membrane Fluorescence Anisotropy
The anisotropy of fluorescence from exponential C. albicans cells labeled by DPH was used to monitor changes in membrane dynamics. The cells (2ϫ10 8 cells in an YPD medium), containing ginsenosides and amphotericin B at various concentrations, were incubated at a physiological temperature of 28°C on a rotary shaker at 140 rpm for 2 h. The control cells were incubated without a compound. The cells were fixed with formaldehyde (0.37% v/v) for 45 min and they were collected by centrifugation at 3000 rpm, washed several times with a PBS buffer (pH 7.4), and the pellets were frozen in liquid nitrogen. For DPH labeling, the pellets were resuspended in a PBS buffer and incubated at 28°C for 45 min in the presence of 0.6 mM of DPH, followed by several washings in a PBS buffer. Steady-state fluorescence anisotropy was measured using a Shimadzu RF-5301PC spectrofluorometer (Kyoto, Japan) at 350 nm excitation and 425 nm emission wavelengths.
16) The results represent the average of triplicate measurements from three independent assays.
RESULTS
In Vitro Antifungal Activity
The antifungal effects of ginsenosides on pathogenic fungi was investigated and described as the minimum inhibitory concentration (MIC). In the current study, amphotericin B was used as a positive control; amphotericin B is a fungicidal agent widely used in treating serious systemic infections. 17) Ginsenosides, in an MIC value of 50-100 mg/ml, showed antifungal activity against human pathogenic fungal strains. Ginsenosides exhibited less potent activity than amphotericin B, showing MIC values of 5 mg/ml on all fungal strains (Table 1) .
To assess the killing potency of ginsenosides, we con- 
Fig. 1. Time Killing Plots for C. albicans by Ginsenosides
The fungal cells were incubated with 100 mg/ml of ginsenosides or 2.5 mg/ml amphotericin B which was used as a positive control. Viability was determined every 2 h by using colony forming units (CFUs) and it was expressed as a percentage of survivals, and the error bars represent the standard deviation (S.D.) values for three independent experiments, performed in triplicate. ducted a time-killing assay. The killing of kinetic assays was done by counting the CFUs of C. albicans. Ginsenosides showed cidal activity against fungal strains. The CFUs of the C. albicans cells, at the MIC value of ginsenosides, decreased rapidly less than the decrease in the presence of amphotericin B, after 1 h (Fig. 1) .
The Effect of Ginsenosides on the Dimorphic Transition of Fungal Cells To investigate the antifungal effect of ginsenosides against C. albicans in the human body, we performed an in vitro test of the antifungal effect on the mycelial forms of C. albicans cells that were induced by supplementing with 20% FBS. As shown in Fig. 2 , the serum-induced mycelia was significantly inhibited from extending and destroyed in the presence of ginsenosides (Fig. 2C) , while the mycelia in the absence of ginsenosides formed normally (Fig. 2B) .
Dissipation of Plasma Membrane Potential To assess whether ginsenosides can affect the faculty of fungal plasma membrane, we investigated the dissipation of fungal plasma membrane potential. C. albicans cells were cultured at 28°C for 3 h, in the presence or absence of ginsenosides and we measured the amounts of accumulated DiBAC 4 (3) in cells with flow cytometry by staining with DiBAC 4 (3). DiBAC 4 (3) has high voltage sensitivity and can enter depolarized cells, where it binds to lipid-rich intracellular components. 15) Ginsenoside-treated C. albicans cells dose-dependently pile up DiBAC 4 (3) more than that of ginsenoside-untreated cells (Fig. 3) .
Change in the Plasma Membrane Dynamics of Fungal Cells The effect of ginsenosides on the fungal plasma membrane was further investigated by using DPH as a membrane probe. If the antifungal activities exerted by ginsenosides on C. albicans are at the level of the plasma membrane, DPH, which interacts with an acyl group of the plasma membrane lipid bilayer, could not be inserted into the membrane. As shown in Fig. 4 , plasma membrane DPH fluorescence anisotropy was significantly decreased by increasing the concentrations of ginsenosides and amphotericin B. This is consistent with the disruption of the plasma membrane by ginsenosides as well as by a positive control, amphotericin B.
DISCUSSION
Plants have developed an arsenal of chemicals in order to survive attacks by microbial invasion. Until now, many different antifungal phytochemicals have been isolated from several plants. Since these compounds have relative novel chemical structures and antifungal mechanisms, there has been a growing interest in antifungal phytochemicals.
18) The present study aimed to assess the antifungal effects of ginsenosides toward pathogenic fungi and their mode of action.
Ginsenosides exhibited less potent antifungal activity against human pathogenic fungal strains than that of amphotericin B regarding MIC values as a positive control (Table  1 ). These results demonstrate the antifungal activity of ginsenosides against fungal pathogen, which can cause human infectious diseases. Most antibiotics show antifungal activity by cidal or static action. Ginsenosides exhibited similar killing potency with amphotericin B, which are known as being a cidal agent toward fungi; the antifungal activity of ginsenosides is due to the killing action, as described by time-killing plots with C. albicans (Fig. 1) . The opportunistic dimorphous pathogen C. albicans is of increasing importance in human medicine, and causes the deeply invasive mycoses including candidiasis. The dimorphic transition of C. albicans from yeast to mycelial form is responsible for the pathogenicity with the mycelial shape being predominantly found during host tissue invasion, and can be induced by temperature, pH, and serum. 19) Ginsenosides also exert antifungal activity on the mycelial structures of C. albicans cells, induced by a FBS (Fig. 2) . This suggests that ginsenosides can be a potential compound or a therapeutic agent in treating fungal infectious diseases in humans. Lee and Han reported that direct interaction of the ginsenoside Rg 1 to C. albicans cells resulted in no growth inhibition. 20) However, these results indicated that direct interaction of several ginsenosides (Rb 1 , Rb 2 , Rc, Rd, Re, Rf, Rg 1 , Rg 2 , Rg 3 , Rh 2 ) to C. albicans cells caused cidal effects.
In general, saponins exhibit ability to be a complex with sterols in fungal membranes which can cause loss of membrane integrity. 21) To provide information on mode of antifungal action of ginsenosides, we investigated their ability to dissipate the membrane potential of C. albicans (Fig. 3) . These results indicate that ginsenosides affect yeast cells by injuring their membranes, thus disrupting membrane potential. Ginsenosides were also measured for their ability to do what to membrane dynamics (Fig. 4) . In this assay, amphotericin B was used as a positive control. In general, amphotericin B binds to membrane sterols and transmembrane pores are formed, thus causing a leakage of cell constituents and eventually cell death. 22) Here, these data were used to assess the global "rigidity" of the plasma membrane through the contrast between ginsenosides and amphotericin B. This decrease in the amount of DPH, after treatment, provides further evidence that ginsenosides act on the plasma membrane, either by specific disruption of the ion channels or by nonspecific pore formation. As for the mechanism by which ginsenosides break down the membrane permeability barrier, it is possible that ginsenosides perturb the membrane lipid bilayers, causing the formation of pores as well as dissipating the electrical potential of the membrane.
In summary, ginsenosides exhibited antifungal effects on pathogenic fungi tested. Although the exact mechanism of ginsenosides action has not yet been fully elucidated, the results reported here indicate its effect on plasma membrane. Therefore, we conclude that ginsenosides have considerable antifungal activity, deserving further investigation for clinical applications.
